GE HealthCare and Medis Medical Imaging have announced a collaboration aimed at advancing precision care in the diagnosis and treatment of coronary artery disease (CAD). The two companies will focus on integrating Medis Quantitative Flow Ratio (Medis QFR), a non-invasive approach to assessing coronary physiology, into GE HealthCare’s interventional cardiology portfolio built around the Allia Platform.

CHICAGO and WASHINGTON, D.C. — The National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next Gen Basketball Players Union (NBGPU) have announced a collaboration with GE HealthCare and MedStar Health to conduct a pioneering research study on musculoskeletal and joint health. This longitudinal pilot study aims to quantify the impact of playing, training, and rest over a professional basketball season.

Chicago, IL – May 5, 2024 – GE HealthCare unveiled SIGNA MAGNUS, a high-performance head-only MR scanner designed to advance the field of neuroscience. The system aims to overcome the limitations faced by conventional whole-body MR systems in exploring complex imaging procedures in neurology, oncology, and psychiatry.The SIGNA MAGNUS system is positioned to revolutionize MR research in the realms of neurology, oncology, and psychiatry. It represents a significant leap forward in the study of psychiatric diseases and neurological disorders such as Alzheimer’s, areas that...